MedTrace Logo

Fixed Lingual Mandibular Growth Modificator

NCT01853137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2020-11-12

Study results available
· View outcomes & findings →

Summary

The current trial was designed to investigate the possible initial net skeletal and dental effects of treatment with FLMGM by a comparative evaluation of treated and untreated Cl II/1 malocclusion subjects. The null hypothesis stated that there were no significant differences in dentofacial changes between FLMGM group and control group.

Conditions

  • Class II Division 1 Malocclusion
  • Retrognathic Mandible

Interventions

DEVICE

Fixed Lingual Mandibular Growth Modificator (FLMGM)

Novel Class II functional appliance, a fixed version of double-plate appliance

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Osama H Alali, PhD · Senior Lecturer, Department of Orthodontics, School of Dentistry, University of Aleppo, Syria

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-07-31
Completion
2012-12-31

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01853137 on ClinicalTrials.gov